White Coats, Dark Money: Day 6
How Academic Medical Centers Became Healthcare’s Apex Predators
THE ROJAS REPORT
They train our doctors.
They conduct our research.
They treat some of the sickest patients.
And they charge and collect the highest prices in American healthcare.
Academic Medical Centers are the prestige factories of the medical world.
They’re also the worst offenders in the nonprofit hospital system.
Today, we look behind the white coats.
The Halo Effect
Academic Medical Centers operate under a unique protection: the halo of prestige.
However, this prestige carries a tangible cost. For instance, regions dominated by AMCs often see health insurance premiums up to 20% higher than national averages, primarily due to the excessive billing rates justified by their reputation. This gap translates to millions in additional healthcare spending for patients, without a significant gain in quality.
When Cleveland Clinic charges and collects more, patients assume it’s because they’re better. When Johns Hopkins sends a massive bill, patients tell themselves they’re paying for excellence.
The prestige is real.
The pricing is predatory.
AMCs charge, on average, 47% more than community hospitals for the same procedures. A joint replacement that costs $60,000 at an AMC might cost $31,800 at a community hospital, yet both can have identical 30-day readmission rates. Not because the outcomes are always better. Because they can.
The brand is the moat.
The Training Pipeline
AMCs control the supply of new physicians through Graduate Medical Education.
Here’s how it works:
Medicare pays hospitals to train resident physicians. In 2024, that was over $16 billion in Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments.
But the number of Medicare-funded residency slots has been capped since 1997. The Balanced Budget Act froze the numbers.
The result?
AMCs control the training pipeline. They decide how many new doctors enter the market. They determine which specialties grow and which don’t.
When there’s a shortage of primary care physicians, it’s not an accident. It’s a structural feature of a system designed by specialists at academic centers.
The AHA and its member AMCs lobby constantly for more GME funding. More slots. More money.
What they don’t lobby for: reforms that would break their monopoly on training.
The Research Complex
In 2024, AMCs received $49 Billion in NIH research funding. This is taxpayer money, funding research that often leads to private patents and commercialization. Take for instance, the case of CAR-T therapies, which are partially funded by NIH grants.
These groundbreaking treatments, while invaluable in fighting certain cancers, can cost patients upwards of $150,000. This highlights how federal investments intended to foster innovation can lead to commercialized medications that carry hefty price tags at the pharmacy. The Bayh-Dole Act of 1980 allowed universities and hospitals to patent discoveries made with federal funding.
The original intent was to accelerate innovation by giving institutions an incentive to commercialize.
The result?
Publicly funded research becomes privately profitable.
You pay twice:
→ Once for the research through NIH grants and your tax dollars
→ Again, for the inflated drug prices when those discoveries become patented treatments
AMCs have become experts at extracting value from the research pipeline. Licensing agreements. Spinoff companies. Patent portfolios.
The academic mission provides cover.
The business model extracts value.
The Facility Fee Goldmine
When an AMC acquires a physician practice, something magical happens to Medicare reimbursement.
Same doctor. Same exam room. Same stethoscope.
But now it’s a “hospital outpatient department.”
Medicare pays more for the same service.
Not based on quality. Medicare wants to pay AMCs more.
(Guess where Medicare employees go after working at Medicare?)
This is why AMCs have been on an acquisition spree for the past two decades. Every independent practice they acquire becomes a facility fee revenue generator.
The AHA fights site-neutral payment reform harder than almost any other policy issue.
Now you know why.
The Community Hospitals They Swallowed
AMCs don’t just dominate through prestige. They dominate through acquisition.
Over the past two decades, academic systems have absorbed community hospitals across the country.
The pattern is consistent:
Acquire a struggling community hospital.
Rebrand it under the AMC name.
Convert physician practices to hospital outpatient departments.
Raise prices
Claim “community benefit” while extracting value
The communities that built these hospitals over generations watch as they become feeders for distant academic empires.
Local boards lose control.
Local priorities get overridden.
Local dollars flow to downtown towers.
The Outcome Paradox
For most conditions, AMCs do not deliver better outcomes than good community hospitals.
They excel at the most complex cases. Rare cancers. Transplants. Experimental procedures. The cases that require the full weight of a research institution.
But for the bread-and-butter of healthcare, joint replacements, commonly performed surgeries, chronic disease management, community hospitals and physician-owned facilities often match or beat AMC outcomes.
At a fraction of the price.
The prestige justifies the pricing.
The data often doesn’t.
The Names
Let’s name them.
Cleveland Clinic
$15.9 billion in revenue (2024). Nonprofit status. Massive commercial real estate holdings. Aggressive physician practice acquisition across Ohio and Florida.
Mayo Clinic
$19.8 billion in revenue (2024). Destination medicine model that serves wealthy out-of-state patients while claiming Minnesota nonprofit tax benefits.
UPMC
$30 billion in revenue (2024). Controls 60% of the Allegheny County hospital market—and over 90% in some rural Pennsylvania areas. Also operates one of the state’s largest health insurers with 4+ million members. The CEO’s compensation exceeded $11 million. Nonprofit.
Johns Hopkins
Historic prestige. Hundreds of millions in annual NIH funding. Aggressive expansion throughout Maryland and now into other states.
Mass General Brigham
Dominates the Boston market alongside competitor Beth Israel Lahey Health. Premium pricing justified by the Harvard name. Expanding footprint across New England.
Duke Health
Dominates North Carolina alongside UNC that benefit from one of the nation’s oldest and most restrictive CON laws.
NewYork-Presbyterian
Columbia and Cornell. Two Ivy League brands. Manhattan pricing.
Stanford Health Care
Silicon Valley pricing in Silicon Valley. Research prestige translates to market power.
Penn Medicine
Philadelphia’s dominant system. The University of Pennsylvania brand is commanding premium rates.
Yale New Haven
Controls Connecticut. Academic prestige meets geographic monopoly.
These are not struggling charities.
These are billion-dollar enterprises with monopoly power, operating under nonprofit protection.
The Lobbying Machine
AMCs are disproportionately powerful in healthcare lobbying.
They have prestige. When a Cleveland Clinic executive testifies before Congress, they’re treated as an authority, not an interested party. They have alumni networks that include senators, governors, and cabinet members. The revolving door spins faster at academic centers. They have research relationships with NIH and FDA that create institutional dependencies.
When an AMC president calls a congressional office, the call gets taken. When an independent physician calls, they get voicemail.
This influence shapes policy: a notable instance of this power is the 2015 delay in site-neutral payment reform, demonstrating how AMCs leverage their prestige into concrete legislative outcomes. By delaying this reform, AMCs continued to benefit from higher reimbursement rates, reinforcing their financial stronghold in the healthcare arena.
This influence shapes policy:
→ GME funding flows to AMCs, not community hospitals
→ Research funding prioritizes academic centers
→ CON laws protect established players
→ The physician-owned hospital ban eliminates competition
The academic mission provides cover.
The lobbying protects the business model.
What Would Reform Look Like?
GME funding reform. Distribute training dollars to community hospitals, not just academic centers. Break the training monopoly, fund residency slots based on community need, and not institutional prestige.
Site-neutral payments. Same service, same price. Period. No more facility fee arbitrage.
Endowment transparency. If you have billions in assets, justify your tax exemption with proportional charity care and no more hoarding.
Price transparency with teeth. Make AMCs publish actual prices, not chargemaster fiction. Enforce it.
Antitrust enforcement. Stop AMCs from acquiring monopoly power. Block mergers that reduce competition. Unwind acquisitions that have already harmed markets.
The Question
Academic Medical Centers do essential work.
They train doctors. They conduct research.
The question is whether important work justifies:
→ Unlimited pricing power
→ Market monopoly
→ Capture of the regulatory system
→ Billions in tax exemptions while suing patients for medical debt
→ Executive compensation in the tens of million, with some CEOs earning up to 200 times the median salary of nurses
The prestige is real.
The abuse is also real.
Tomorrow
The Path Forward.
Six days of diagnosis. Tomorrow we prescribe.
A blueprint for physician independence in 2025.
What it takes to compete. What it takes to win. What reform actually looks like.
10 AM Central. Series finale.
This is Day 6 of a series exposing the structure of American healthcare. Subscribe to get each installment.
References
[1] Congressional Research Service. (2025, August 19). Federal Support for Graduate Medical Education.
[2] AAMC. (2023). Medicaid Graduate Medical Education Payments: Results from the 2022 50-State Survey.
[3] American Hospital Association. (n.d.). Medical Education.
[4] AAMC. (n.d.). GME Advocacy.
[5] Centers for Medicare & Medicaid Services. (n.d.). Direct Graduate Medical Education (DGME).
[6] National Center for Biotechnology Information. (2014). Governance - Graduate Medical Education That Meets the Nation’s Health Needs.
[7] ACGME. (2022, August 30). ACGME Answers: Explaining GME Position Allotment.
[8] American Hospital Association. (2025). AHA 2025 Advocacy Agenda.
[9] Cleveland Clinic. (2025, March). Unaudited Consolidated Financial Statements and Other Financial Information, Fourth Quarter 2024.
[10] Finance Yahoo. (2025, March). 2024 was a record year for Mayo Clinic revenue.
[11] The Solidarity Center. (2023). Appendix: UPMC Market Share Analysis.
[12] Paddock Post. (2024, December). Executive Compensation at UPMC (Pittsburgh) 2023.
[13] STAT News. (2024, December). Mass. primary care doctors are switching between rival health systems.
[14] North Carolina General Assembly. (n.d.). Overview of North Carolina Certificate of Need Law.
[15] UPMC. (n.d.). By the Numbers: UPMC Facts and Figures.
[16] National Conference of State Legislatures. (2024, April). Certificate of Need State Laws.
[17] Mass General Brigham. (2024, December). Mass General Brigham Reports 2024 Financial Results.
Share This With Someone Who Needs to See It
Know a physician who trained at one of these institutions? Who works at one now? Who competes against one?
Please share this with them.
The prestige is real. The abuse is also real.
They need to see both.
Support Independent Healthcare Journalism
The Rojas Report is reader-supported. No pharma ads. No hospital sponsors. No AMC underwriters.
Just the truth about who runs American healthcare—and how to take it back.
Tomorrow is the series finale. If you’ve been reading for free, now is the time.
-Rojas out
We have shared your Substack with Senator Ron Johnson who is holding (or just held) hearings about Obamacare and with our independent minded Medicare insurance agent. We truly hope they will subscribe to and read your newsletter.
Your exposés are amazing and so needed. We wish ordinary citizens could do more, but the market and legislators—with few exceptions—are completely captive and benefit from the abuses you have revealed.
Great job, but you forgot to include Vanderbilt. They are a cancer on the SouthEast region of the US.